Novo Holdings A/S

Novo Holdings is the holding company of the Novo Group, managing the wealth of the Novo Nordisk Foundation and investing in life science companies at all stages of development, as well as a broad portfolio of equity and fixed income securities and real assets.

Novo Ventures is a global team of investment professionals employed by Novo affiliates that supports Novo Holdings’ investments in private, public, and structured product opportunities in the life sciences industry. Novo Ventures is one of the largest international life science venture investors with a diversified portfolio of private and public biotech, medtech, and digital health investments in the US, Europe and Asia. Novo Ventures has a 20+ year track record of investing in novel technologies, from early, translatable science through revenue-generating commercial opportunities. Novo Ventures makes investments in Series A, B and later rounds and invests in IPOs and public life science companies. In addition, Novo Ventures makes selective investments in other life science investment managers for strategic and financial returns. The Novo Ventures investment team has colleagues on the ground in Copenhagen, London, San Francisco and Boston.